Generic placeholder image

Current Gene Therapy

Author(s): Tarwadi Tarwadi, Jalal A. Jazayeri*, Sabar Pambudi, Alfan D. Arbianto, Heni Rachmawati, Rahmana E. Kartasasmita and Sukmadjaja Asyarie

DOI: 10.2174/1566523220666201005104224

DownloadDownload PDF Flyer Cite As
In-silico Molecular Interaction of Short Synthetic Lipopeptide/Importin-alpha and In-vitro Evaluation of Transgene Expression Mediated by Liposome- Based Gene Carrier

Page: [383 - 394] Pages: 12

  • * (Excluding Mailing and Handling)

Abstract

Background: Lipopeptide-based gene carriers have shown low cytotoxicity, are capable of cell membrane penetration, are easy to manufacture and therefore are great potential candidates for gene delivery applications.

Objectives: This study aims to explore a range of short synthetic lipopeptides, (Lau: Lauryl; Pal: Palmitoyl) consisting of an alkyl chain, one cysteine (C), 1 to 2 histidine (H), and lysine (K) residues by performing in-silico molecular interaction and in-vitro evaluation.

Methods: The molecular interactions between the lipopeptides and Importin-α receptor were performed using AutoDock Vina and Amber14. The lipopeptide/DNA complexes were evaluated in- -vitro for their interactions, particle size, zeta potential and transgene expression. Transfection efficiency of the lipopeptides and Pal-CKKHH-derived liposome was carried out based on luciferase transgene expression.

Results: The in-silico interaction showed that Lau-CKKH and Pal-CKKHH hypothetically expedited nuclear uptake. Both lipopeptides had lower binding energy (-6.3 kcal/mol and -6.2 kcal/mol, respectively), compared to the native ligand, viz, nuclear localization sequence (-5.4 kcal/mol). The short lipopeptides were able to condense DNA molecules and efficiently form compacted nanoparticles. Based on the in-vitro evaluation on COS-7, Pal-CKKHH was found to be the best transfection agent amongst the lipopeptides. Its transfection efficiency (ng Luc/mg total protein) increased up to ~3-fold higher (1163 + 55) as it was formulated with helper lipid DOPE (1:2). The lipopeptide- based liposome (Pal-CKKHH: DOPE=1:2) also facilitated luciferase transgene expression on human embryonic kidney cells (293T) and human cervical adenocarcinoma cells (HeLa) with transfection efficiency 1779 +52 and 260 + 22, respectively.

Conclusion: Our study for the first time has shown that the fully synthesized short lipopeptide Pal- CKKHH is able to interact firmly with the Importin-α. The lipopeptide is able to condense DNA molecules efficiently, facilitate transgene expression, expedite the nuclear uptake process, and hence has the characteristics of a potential transfection agent.

Keywords: Lipopeptide, importin- α, in-silico, liposome, particle size, transfection.

Graphical Abstract

[1]
Naldini L. Gene therapy returns to centre stage. Nature 2015; 526(7573): 351-60.
[http://dx.doi.org/10.1038/nature15818] [PMID: 26469046]
[2]
Ginn SL, Amaya AK, Alexander IE, Edelstein M, Abedi MR. Gene therapy clinical trials worldwide to 2017: An update. J Gene Med 2018; 20(5): e3015.
[http://dx.doi.org/10.1002/jgm.3015] [PMID: 29575374]
[3]
Yang C, Uertz J, Yohan D, Chithrani BD. Peptide modified gold nanoparticles for improved cellular uptake, nuclear transport, and intracellular retention. Nanoscale 2014; 6(20): 12026-33.
[http://dx.doi.org/10.1039/C4NR02535K] [PMID: 25182693]
[4]
Hillyar CR, Cornelissen B, Vallis KA. Uptake, internalization and nuclear translocation of radioimmunotherapeutic agents. Ther Deliv 2014; 5(3): 319-35.
[http://dx.doi.org/10.4155/tde.14.6] [PMID: 24592956]
[5]
Kurrikoff K, Veiman KL, Künnapuu K, et al. Effective in vivo gene delivery with reduced toxicity, achieved by charge and fatty acid -modified cell penetrating peptide. Sci Rep 2017; 7(1): 17056.
[http://dx.doi.org/10.1038/s41598-017-17316-y] [PMID: 29213085]
[6]
Sun Y, Chen L, Sun F, Tian X, Luo SZ. New amphiphilic N-phosphoryl oligopeptides designed for gene delivery. Int J Pharm 2014; 468(1-2): 83-90.
[http://dx.doi.org/10.1016/j.ijpharm.2014.04.007] [PMID: 24709211]
[7]
Koloskova OO, Nikonova AA, Budanova UA, et al. Synthesis and evaluation of novel lipopeptide as a vehicle for efficient gene delivery and gene silencing. Eur J Pharm Biopharm 2016; 102: 159-67.
[http://dx.doi.org/10.1016/j.ejpb.2016.03.014] [PMID: 26992289]
[8]
Ho JK, White PJ, Pouton CW. Self-crosslinking lipopeptide/DNA/PEGylated particles: A new platform for DNA vaccination designed for assembly in aqueous solution. Mol Ther Nucleic Acids 2018; 12: 504-17.
[http://dx.doi.org/10.1016/j.omtn.2018.05.025] [PMID: 30195787]
[9]
Biswas A, Chakraborty K, Dutta C, et al. Engineered histidine-enriched facial lipopeptides for enhanced intracellular delivery of functional siRNA to triple negative breast cancer cells. ACS Appl Mater Interfaces 2019; 11(5): 4719-36.
[http://dx.doi.org/10.1021/acsami.8b13794] [PMID: 30628773]
[10]
Kosugi S, Hasebe M, Matsumura N, et al. Six classes of nuclear localization signals specific to different binding grooves of importin alpha. J Biol Chem 2009; 284(1): 478-85.
[http://dx.doi.org/10.1074/jbc.M807017200] [PMID: 19001369]
[11]
Tarwadi JA, Jazayeri JA, Prankerd RJ, Pouton CW. Preparation and in vitro evaluation of novel lipopeptide transfection agents for efficient gene delivery. Bioconjug Chem 2008; 19(4): 940-50.
[http://dx.doi.org/10.1021/bc700463q] [PMID: 18333604]
[12]
Fontes MR, Teh T, Kobe B. Structural basis of recognition of monopartite and bipartite nuclear localization sequences by mammalian importin-alpha. J Mol Biol 2000; 297(5): 1183-94.
[http://dx.doi.org/10.1006/jmbi.2000.3642] [PMID: 10764582]
[13]
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31(2): 455-61.
[PMID: 19499576]
[14]
Tarwadi SP, Rachmawati H, Kartasasmita RE, Asyarie Sa, Jalal A, Jazayeri CW. Pouton, Nanoparticle evaluation of synthetic Palmitoyl-CKKHH as transfection reagent for non-viral gene delivery vehicle. Int J Eng Res Appl 2018; 8(1): 40-8.
[15]
Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009; 30(16): 2785-91.
[http://dx.doi.org/10.1002/jcc.21256] [PMID: 19399780]
[16]
Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des 2010; 24(5): 417-22.
[http://dx.doi.org/10.1007/s10822-010-9352-6] [PMID: 20401516]
[17]
Wang R, Lai L, Wang S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J Comput Aided Mol Des 2002; 16(1): 11-26.
[http://dx.doi.org/10.1023/A:1016357811882] [PMID: 12197663]
[18]
Mochizuki S, Kanegae N, Nishina K, et al. The role of the helper lipid dioleoylphosphatidylethanolamine (DOPE) for DNA transfection cooperating with a cationic lipid bearing ethylenediamine. Biochim Biophys Acta 2013; 1828(2): 412-8.
[http://dx.doi.org/10.1016/j.bbamem.2012.10.017] [PMID: 23092705]
[19]
Åmand HL, Nordén B, Fant K. Functionalization with C-terminal cysteine enhances transfection efficiency of cell-penetrating peptides through dimer formation. Biochem Biophys Res Commun 2012; 418(3): 469-74.
[http://dx.doi.org/10.1016/j.bbrc.2012.01.041] [PMID: 22281502]
[20]
Ong ZY, Yang C, Cheng W, et al. Biodegradable cationic poly(carbonates): Effect of varying side chain hydrophobicity on key aspects of gene transfection. Acta Biomater 2017; 54: 201-11.
[http://dx.doi.org/10.1016/j.actbio.2017.03.027] [PMID: 28323177]
[21]
Perrone B, Miles AJ, Salnikov ES, Wallace BA, Bechinger B. Lipid interactions of LAH4, a peptide with antimicrobial and nucleic acid transfection activities. Eur Biophys J 2014; 43(10-11): 499-507.
[http://dx.doi.org/10.1007/s00249-014-0980-y] [PMID: 25182242]
[22]
Kichler A, Mason AJ, Marquette A, Bechinger B. Histidine-rich cationic cell-penetrating peptides for plasmid DNA and siRNA delivery. Methods Mol Biol 2019; 1943: 39-59.
[http://dx.doi.org/10.1007/978-1-4939-9092-4_3] [PMID: 30838608]
[23]
Mann A, Shukla V, Khanduri R, Dabral S, Singh H, Ganguli M. Linear short histidine and cysteine modified arginine peptides constitute a potential class of DNA delivery agents. Mol Pharm 2014; 11(3): 683-96.
[http://dx.doi.org/10.1021/mp400353n] [PMID: 24476132]
[24]
Ju J, Huan M-L, Wan N, Qiu H, Zhou S-Y, Zhang B-L. Novel cholesterol-based cationic lipids as transfecting agents of DNA for efficient gene delivery. Int J Mol Sci 2015; 16(3): 5666-81.
[http://dx.doi.org/10.3390/ijms16035666] [PMID: 25768346]
[25]
Muñoz-Ubeda M, Rodríguez-Pulido A, Nogales A, Martín-Molina A, Aicart E, Junquera E. Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol/DOPE-DNA lipoplexes. Biomacromolecules 2010; 11(12): 3332-40.
[http://dx.doi.org/10.1021/bm1008124] [PMID: 21058732]
[26]
Du Z, Munye MM, Tagalakis AD, Manunta MD, Hart SL. The role of the helper lipid on the DNA transfection efficiency of lipopolyplex formulations. Sci Rep 2014; 4: 7107.
[http://dx.doi.org/10.1038/srep07107] [PMID: 25407686]
[27]
Tassler S, Dobner B, Lampp L, et al. DNA delivery systems based on peptide-mimicking cationic lipids-the effect of the co-lipid on the structure and DNA binding capacity. Langmuir 2019; 35(13): 4613-25.
[http://dx.doi.org/10.1021/acs.langmuir.8b04139] [PMID: 30840475]